Literature DB >> 26795593

Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy.

Katherine L Helbig1, Kelly D Farwell Hagman1, Deepali N Shinde1, Cameron Mroske1, Zöe Powis1, Shuwei Li2, Sha Tang1, Ingo Helbig3,4.   

Abstract

PURPOSE: To assess the yield of diagnostic exome sequencing (DES) and to characterize the molecular findings in characterized and novel disease genes in patients with epilepsy.
METHODS: In an unselected sample of 1,131 patients referred for DES, overall results were compared between patients with and without epilepsy. DES results were examined based on age of onset and epilepsy diagnosis.
RESULTS: Positive/likely positive results were identified in 112/293 (38.2%) epilepsy patients compared with 210/732 (28.7%) patients without epilepsy (P = 0.004). The diagnostic yield in characterized disease genes among patients with epilepsy was 33.4% (105/314). KCNQ2, MECP2, FOXG1, IQSEC2, KMT2A, and STXBP1 were most commonly affected by de novo alterations. Patients with epileptic encephalopathies had the highest rate of positive findings (43.4%). A likely positive novel genetic etiology was proposed in 14/200 (7%) patients with epilepsy; this frequency was highest in patients with epileptic encephalopathies (17%). Three genes (COQ4, DNM1, and PURA) were initially reported as likely positive novel disease genes and were subsequently corroborated in independent peer-reviewed publications.
CONCLUSION: DES with analysis and interpretation of both characterized and novel genetic etiologies is a useful diagnostic tool in epilepsy, particularly in severe early-onset epilepsy. The reporting on novel genetic etiologies may further increase the diagnostic yield.Genet Med 18 9, 898-905.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26795593     DOI: 10.1038/gim.2015.186

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  38 in total

Review 1.  Diagnostic clinical genome and exome sequencing.

Authors:  Leslie G Biesecker; Robert C Green
Journal:  N Engl J Med       Date:  2014-06-19       Impact factor: 91.245

Review 2.  Gene hunting in autism spectrum disorder: on the path to precision medicine.

Authors:  Daniel H Geschwind; Matthew W State
Journal:  Lancet Neurol       Date:  2015-04-16       Impact factor: 44.182

3.  Clinical whole exome sequencing in child neurology practice.

Authors:  Siddharth Srivastava; Julie S Cohen; Hilary Vernon; Kristin Barañano; Rebecca McClellan; Leila Jamal; SakkuBai Naidu; Ali Fatemi
Journal:  Ann Neurol       Date:  2014-08-30       Impact factor: 10.422

4.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.

Authors:  Sarah E Soden; Carol J Saunders; Laurel K Willig; Emily G Farrow; Laurie D Smith; Josh E Petrikin; Jean-Baptiste LePichon; Neil A Miller; Isabelle Thiffault; Darrell L Dinwiddie; Greyson Twist; Aaron Noll; Bryce A Heese; Lee Zellmer; Andrea M Atherton; Ahmed T Abdelmoity; Nicole Safina; Sarah S Nyp; Britton Zuccarelli; Ingrid A Larson; Ann Modrcin; Suzanne Herd; Mitchell Creed; Zhaohui Ye; Xuan Yuan; Robert A Brodsky; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

5.  The usefulness of whole-exome sequencing in routine clinical practice.

Authors:  Alejandro Iglesias; Kwame Anyane-Yeboa; Julia Wynn; Ashley Wilson; Megan Truitt Cho; Edwin Guzman; Rebecca Sisson; Claire Egan; Wendy K Chung
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

6.  COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency.

Authors:  Gloria Brea-Calvo; Tobias B Haack; Daniela Karall; Akira Ohtake; Federica Invernizzi; Rosalba Carrozzo; Laura Kremer; Sabrina Dusi; Christine Fauth; Sabine Scholl-Bürgi; Elisabeth Graf; Uwe Ahting; Nicoletta Resta; Nicola Laforgia; Daniela Verrigni; Yasushi Okazaki; Masakazu Kohda; Diego Martinelli; Peter Freisinger; Tim M Strom; Thomas Meitinger; Costanza Lamperti; Atilano Lacson; Placido Navas; Johannes A Mayr; Enrico Bertini; Kei Murayama; Massimo Zeviani; Holger Prokisch; Daniele Ghezzi
Journal:  Am J Hum Genet       Date:  2015-02-05       Impact factor: 11.025

7.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.

Authors:  Holly LaDuca; A J Stuenkel; Jill S Dolinsky; Steven Keiles; Stephany Tandy; Tina Pesaran; Elaine Chen; Chia-Ling Gau; Erika Palmaer; Kamelia Shoaepour; Divya Shah; Virginia Speare; Stephanie Gandomi; Elizabeth Chao
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

8.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

9.  Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.

Authors:  Andreas Gnirke; Alexandre Melnikov; Jared Maguire; Peter Rogov; Emily M LeProust; William Brockman; Timothy Fennell; Georgia Giannoukos; Sheila Fisher; Carsten Russ; Stacey Gabriel; David B Jaffe; Eric S Lander; Chad Nusbaum
Journal:  Nat Biotechnol       Date:  2009-02-01       Impact factor: 54.908

10.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

View more
  109 in total

Review 1.  Genetic Testing in Pediatric Epilepsy.

Authors:  Tristan T Sands; Hyunmi Choi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

Review 2.  Intractable Generalized Epilepsy: Therapeutic Approaches.

Authors:  Sean T Hwang; Scott J Stevens; Aradia X Fu; Simona V Proteasa
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-26       Impact factor: 5.081

Review 3.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

4.  Neuronal deficiency of ARV1 causes an autosomal recessive epileptic encephalopathy.

Authors:  Elizabeth E Palmer; Kelsey E Jarrett; Rani K Sachdev; Fatema Al Zahrani; Mais Omar Hashem; Niema Ibrahim; Hugo Sampaio; Tejaswi Kandula; Rebecca Macintosh; Rajat Gupta; Donna M Conlon; Jeffrey T Billheimer; Daniel J Rader; Kouichi Funato; Christopher J Walkey; Chang Seok Lee; Christine Loo; Susan Brammah; George Elakis; Ying Zhu; Michael Buckley; Edwin P Kirk; Ann Bye; Fowzan S Alkuraya; Tony Roscioli; William R Lagor
Journal:  Hum Mol Genet       Date:  2016-06-06       Impact factor: 6.150

Review 5.  Resolving the Micro-Macro Disconnect to Address Core Features of Seizure Networks.

Authors:  Jordan S Farrell; Quynh-Anh Nguyen; Ivan Soltesz
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

6.  Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.

Authors:  Weiting Tang; Ding Liu; Stephen F Traynelis; Hongjie Yuan
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

7.  Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study.

Authors:  Iván Sánchez Fernández; Tobias Loddenkemper; Marina Gaínza-Lein; Beth Rosen Sheidley; Annapurna Poduri
Journal:  Neurology       Date:  2019-01-04       Impact factor: 9.910

8.  Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.

Authors:  Ciria C Hernandez; Wenshu XiangWei; Ningning Hu; Dingding Shen; Wangzhen Shen; Andre H Lagrange; Yujia Zhang; Lifang Dai; Changhong Ding; Zhaohui Sun; Jiasheng Hu; Hongmin Zhu; Yuwu Jiang; Robert L Macdonald
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

9.  De Novo Mutations and Rare Variants Occurring in NMDA Receptors.

Authors:  Wenshu XiangWei; Yuwu Jiang; Hongjie Yuan
Journal:  Curr Opin Physiol       Date:  2017-12-27

10.  Hodgkin-Huxley-Katz Prize Lecture: Genetic and pharmacological control of glutamate receptor channel through a highly conserved gating motif.

Authors:  Riley E Perszyk; Scott J Myers; Hongjie Yuan; Alasdair J Gibb; Hiro Furukawa; Alexander I Sobolevsky; Stephen F Traynelis
Journal:  J Physiol       Date:  2020-06-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.